SUBJECT-0442.dossier · company · status: active
MK
subject of file

Merck KGaA

German pharmaceutical company
Tracked because German pharmaceutical company · 5 documented connections
Facts on record4
Connections mapped5
Sources cited16
Evidence: 1S 3I
Stated vs Revealed
No documented contradictions on file.
[PUBLIC COST ESTIMATE]
Documented financial relationships span 0 money flow chains, while 2 elected officials hold documented connections.
0Money Chains
0Traced Hops
Connected Officials
Calculation Methodology

Contract values are summed from documented money flow chains where this entity appears as a source or destination node. Amounts are drawn from USASpending.gov, FEC filings, SEC EDGAR, or LD-2 lobbying registrations.

Donor contributions aggregate documented amounts from the donor_interests table, sourced from FEC individual and PAC contribution filings.

Connected officials are elected officials in our database with a mapped relationship (lobbying, board membership, campaign contribution, etc.) to this entity.

Annualised flow represents the total documented dollar amount traced through money flow hops involving this entity. Where hop-level amounts are unavailable, the chain-level documented total is used as a conservative upper bound.

All figures are drawn from public filings. Estimates are conservative — undisclosed transactions, dark money, and vanish-point hops are excluded from totals. This is a minimum documented floor, not a ceiling.

PATTERN organization → [donor] → person → [investor] → company 235× PATTERN person → [investor] → company 92× PATTERN person → [colleague] → person → [investor] → company 54× PATTERN company → [investor] → person → [colleague] → person 54× PATTERN person → [donor] → company → [investor] → institution 51×
Connection Map
Key Connections
← Patrick Vallance person
former professional role
Before becoming Chief Scientific Adviser, Vallance was President of Research and Development at Merck KGaA (the German pharmaceutical company), where he worked from 2012 to 2017.
← Sara Jacobs person
investor
Jacobs' 2020 financial disclosure shows millions invested in pharmaceutical company Merck.
← Bill & Melinda Gates Foundation institution
investor
The foundation disbursed over $500 million to pharmaceutical companies including Merck for vaccine development, while the Gates Foundation Trust held equity positions in pharmaceutical companies creating a documented conflict of interest.
← Deborah K. Ross person
donor
In May 2024, Ross received campaign donations from the CEO of Merck (among other pharmaceutical CEOs), and Pharmaceuticals/Health Products was a top industry donor at $101,295.
← Palantir Technologies company
partner
Joint partnership through EMD Digital for Syntropy cancer research platform in 2020
Facts (4)
Data Freshness
Ageing Last update: 160d ago · Avg age: 1491d
Confidence Tiers: Primary Source — cross-referenced government/corporate filings Pending Review — sourced but not independently verified AI Inference — analytical hypothesis from cross-referencing
✓ Verified Findings (1)
Independently re-checked: a second model read the source artifact and confirmed it supports the extracted claim.
✓ verified Pending Review Merck KGaA filed filing with the SEC on 2023-01-27. Accession number: N/A.
Date: 2023-01-27 Added: 08 Apr 2026 SEC FILING SEC EDGAR: filing — Merck KGaA (2023-01-27)
All Connections (5)
← Palantir Technologies company
partner confirmed
Joint partnership through EMD Digital for Syntropy cancer research platform in 2020
← Patrick Vallance person
former professional role primary since 2012
Before becoming Chief Scientific Adviser, Vallance was President of Research and Development at Merck KGaA (the German pharmaceutical company), where he worked from 2012 to 2017.
investor primary since 2021
The foundation disbursed over $500 million to pharmaceutical companies including Merck for vaccine development, while the Gates Foundation Trust held equity positions in pharmaceutical companies creating a documented conflict of interest.
← Deborah K. Ross person
donor primary since 2024
In May 2024, Ross received campaign donations from the CEO of Merck (among other pharmaceutical CEOs), and Pharmaceuticals/Health Products was a top industry donor at $101,295.
← Sara Jacobs person
investor primary since 2020
Jacobs' 2020 financial disclosure shows millions invested in pharmaceutical company Merck.
Sources (16)
2026 UNVERIFIED Research: Merck KGaA — Parliamentary records (no results) parliamentary_record Processed 📜 Receipt
2026-05-09 UNVERIFIED SEARCH_ERROR: Merck KGaA not found in opencorporates claim_flag Processed 📜 Receipt
2026 UNVERIFIED Research: Merck KGaA — Court records (no results) court_document Processed 📜 Receipt
2026 UNVERIFIED Research: Merck KGaA — Lobbying disclosures (no results) government_disclosure Processed 📜 Receipt
2026 UNVERIFIED Research: Merck KGaA — Corporate registrations (no results) government_disclosure Processed 📜 Receipt
2026 UNVERIFIED Research: Merck KGaA — USASpending contracts (no results) contract Processed 📜 Receipt
2022-01-24 SEC FILING SEC EDGAR: filing — Merck KGaA (2022-01-24) sec_filing Processed 📜 Receipt
2021-01-08 SEC FILING SEC EDGAR: filing — Merck KGaA (2021-01-08) sec_filing Processed 📜 Receipt
2024-02-14 SEC FILING SEC EDGAR: filing — Merck KGaA (2024-02-14) sec_filing Processed 📜 Receipt
2023-01-27 SEC FILING SEC EDGAR: filing — Merck KGaA (2023-01-27) sec_filing Processed 📜 Receipt